rs4252130 — PLG PLG promoter/intronic variant

PLG Intronic Variant — When Plasminogen Expression Runs Low

Plasminogen is a liver-secreted zymogen that circulates in the blood and anchors to cell surfaces, fibrin clots, and invading pathogens. When activated by tissue plasminogen activator (tPA) or urokinase (uPA)¹¹ tissue plasminogen activator (tPA) or urokinase (uPA)
serine proteases that convert inactive plasminogen into the active enzyme plasmin, it becomes plasmin — a broad-spectrum protease that dissolves fibrin clots, clears damaged extracellular matrix, recruits macrophages, and helps the immune system track down and destroy pathogens. Rs4252130 tags a haplotype in the PLG gene region that subtly lowers plasminogen output, compressing every downstream function that depends on adequate plasmin activity.

The Mechanism

Rs4252130 (c.1587+155A>C) sits 155 base pairs into an intron of PLG on chromosome 6q26. The PLG gene is on the plus strand, so the alleles reported by genome files match the coding strand directly. The C allele is the variant form, present in about 29% of Europeans but nearly absent in East Asians (under 0.2%). This striking population stratification pattern is typical of regulatory haplotypes under positive or balancing selection²² positive or balancing selection. Though the intronic position itself may not be the causal site, it tags a regional LD block that includes multiple PLG variants associated with reduced plasma plasminogen levels and altered gene expression in liver and osteoblasts. The precise molecular mechanism — whether altered enhancer activity, splicing regulation, or transcription factor binding — has not been characterised for this specific position.

The Evidence

A GWAS of 3,456 healthy individuals³³ A GWAS of 3,456 healthy individuals identified the PLG locus on chr6q26 as the primary genetic determinant of plasma plasminogen levels, with 9 of 11 genome-wide significant SNPs clustering near PLG or the adjacent LPA gene. The lead missense variant (rs4252129, R523W) reduces levels by 13.4% per allele, and adjacent intronic variants in LD tag the same haplotype. Heritability of plasminogen levels was estimated at 48–60%, with identified variants collectively explaining 6.8%.

Schaefer et al. 2015⁴⁴ Schaefer et al. 2015 identified PLG intronic variant rs4252120 — a near neighbour of rs4252130 with identical population allele frequency profiles — as significantly associated with aggressive periodontitis (OR 1.27, p=5.9×10⁻⁵) and shared genetic risk with coronary artery disease, implicating the PLG haplotype in both mucosal immunity and vascular biology.

Munz et al. 2017⁵⁵ Munz et al. 2017 refined the genetic signal downstream of PLG, finding rs1247559 associated with aggressive periodontitis (OR 1.33) and chronic periodontitis (OR 1.15), while also serving as an eQTL for PLG expression in osteoblasts (p=6.9×10⁻⁵). A landmark Science paper (Silva et al. 2021)⁶⁶ Science paper (Silva et al. 2021) demonstrated the causal mechanism: when plasmin-mediated fibrinolysis fails, fibrin accumulates at mucosal surfaces, aberrantly activates neutrophils through αMβ2 integrin, and triggers destructive NET formation and oxidative bursts. PLG polymorphisms from the D-ARIC cohort were associated with common periodontal disease through this pathway.

Beyond periodontitis, plasminogen-deficient mice show 60–90% reductions in macrophage phagocytosis of apoptotic cells Ploplis & Castellino 2014⁷⁷ Ploplis & Castellino 2014, and plasmin is required for macrophage polarization from pro-inflammatory (M1) to resolution-phase (M2) phenotypes Heissig et al. 2020⁸⁸ Heissig et al. 2020.

Practical Actions

Carriers of one or two C alleles have modestly reduced plasminogen-driven fibrinolysis and macrophage function. This does not produce disease on its own but shifts the immune baseline toward less efficient mucosal clearance and wound resolution. The most actionable implications are in periodontal health maintenance and monitoring for conditions where fibrinolytic clearance matters — respiratory, mucosal, and wound-healing contexts.

Interactions

Interaction with the pathogenic PLG variant rs73015965⁹⁹ rs73015965 (K38E, p.Lys38Glu) is possible in principle: a compound heterozygote carrying one severely reduced-activity K38E allele and one expression-reducing haplotype (tagged by rs4252130) would have lower total plasmin activity than either variant alone. This would be expected to increase risk for ligneous periodontitis or mucous membrane complications beyond what either variant predicts independently. However, direct empirical data on this specific combination are lacking.

The PLG region also interacts with LPA (lipoprotein-a): the LPA gene, immediately adjacent on 6q26, affects both plasminogen activation and cardiovascular risk. Carriers of C alleles at rs4252130 who also carry high-Lp(a) alleles at LPA may have compounded vascular risk through impaired fibrinolysis alongside elevated Lp(a).